Dr. Desiree Ramirez Queza, MD

Dr. Queza practices at Kaiser Permanente South Bay Medical Center in Harbor City, California, part of Kaiser Permanente.

Dr. Queza's NPI, 1578611513, was assigned on January 8, 2007. Dr. Queza graduated from De La Salle University College of Medicine in 2000. Dr. Queza holds California license A96684.

Dr. Queza's primary practice is Kaiser Permanente South Bay Medical Center, at 25825 South Vermont Avenue, Harbor City, CA 90710 in Los Angeles County. The practice phone is (310) 325-5111.

Dr. Queza's primary practice is Kaiser Permanente South Bay Medical Center in Harbor City, California, part of Kaiser Permanente. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Queza to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Queza practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Queza's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Queza is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Queza's licenses on file in 2 states: California and Hawaii.

Dmand AI lists chronic anemia and pneumonia among the conditions Dr. Queza treats.

CMS data shows 17 Medicare services from Dr. Queza across 1 procedure code in 2024, all of them office visits, for 24 Medicare patients. Medicare paid $1,698 for them. Every service was in an office.

CMS counts 24 Medicare patients who saw Dr. Queza in 2024. 75% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 3.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Queza's median patient age at 65, with 57% women.

In 2024, Dr. Queza wrote 488 Medicare Part D claims for 271 patients. 90% of them were for generic drugs. CMS names the drug for 209 of them, across 11 drugs with 11 or more claims each, at $2,462 in total drug cost. In 2023, CMS named 254 claims across 14 drugs.

Dr. Queza accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Queza as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Queza from 1 drug or device company in 2021. Food and beverage make up the largest share, 100% of the total. Dexcom, Inc. paid the most, $20.

Dmand AI lists 1 award for Dr. Queza, most recently CMS Stage 1 2012 in 2011.

Dr. Queza graduated from De La Salle University College of Medicine in 2000.

Dr. Queza is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.